Skip to main content

1 Result(s)

within P. Bellaviti Buttoni Remove this filter

and

  1. No Access

    Article

    Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas

    The optimal duration of cabergoline (CAB) treatment of prolactinomas that minimizes recurrences is not well established. 2011 Endocrine Society Guidelines suggested that withdrawal may be safely undertaken aft...

    E. Sala, P. Bellaviti Buttoni, E. Malchiodi… in Journal of Endocrinological Investigation (2016)